Navigation Links
Summary Judgment Granted for SEROQUEL(R) Patent Litigation
Date:7/1/2008

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). The ANDAs sought approval to market generic versions of SEROQUEL(R) (quetiapine fumarate) tablets in the US before SEROQUEL's patent expires in 2011. Since the Court granted AstraZeneca's motion for Summary Judgment of No Inequitable Conduct in its entirety, trial is unnecessary.

"We are pleased with the Court's decision to uphold our valid intellectual property. SEROQUEL remains an important part of our company's portfolio benefiting patients and physicians throughout the world," said David Brennan, CEO of AstraZeneca.

AstraZeneca's Motion for Summary Judgment of No Inequitable Conduct sought judgment on all of the remaining liability issues in the case. Teva and Sandoz had already conceded infringement and the validity of AstraZeneca's patent. Thus, only the inequitable conduct contentions remained to be resolved. The Court had previously set a date for trial beginning on August 11, 2008.

Important Safety Information for SEROQUEL

SEROQUEL is indicated for the treatment of depressive episodes in bipolar disorder; acute manic episodes in bipolar I disorder, as either monotherapy or adjunct therapy to lithium or divalproex; for the maintenance treatment of bipolar I disorder as adjunct therapy to lithium or divalproex; and schizophrenia. Patients should be periodically reassessed to determine the need for continued treatment and the appropriate dose.

Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk (1.6 to 1.7 times) of death, co
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
2. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
3. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
4. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
5. Par Pharmaceutical Provides Summary of Analyst/Investor Day
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
8. Exercising judgment: The psychology of fitness
9. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
10. St. Davids HealthCare Granted the States Top Honor for Quality and Performance Excellence
11. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...Urology (EAU) and Europa Uomo, the European,advoc..., have entered into an,affiliated partnership as ... improve,patient awareness in Europe with regards...brahamsson, Secretary-General of the EAU: "Thanks ... Uomo will gain access to the latest information o...
(Date:11/30/2009)...ital has launched a series of clinical trials in o...eatment. This approach involves the application of...umour cells from the patient him or herself and de...gressive and frequent malignant tumours. The new t...ombined with the standard, first-line treatment in...
(Date:11/30/2009)... time, so do knees, internal injuries, study finds...-- If you,re a middle-age weekend warrior who like... note: A new study suggests that high levels of ph...mage that could lead to osteoarthritis. , The s...e people who showed no symptoms and had a healthy ...
(Date:11/30/2009)...rs online giving catalog to help families make cha...GTON, Nov. 30 In spite ...his holiday season willing to support charities in...to their own wallets to support charities and near...o charity instead of buying them a gift, according...
(Date:11/30/2009)...v. 30 Stryker Corporatio...ement to acquire privately held Ascent Healthcare...sing and remanufacturing of medical devices in the...yker will acquire Ascent Healthcare Solutions for ...ng is conditioned on the expiration or termination...
Breaking Medicine News(10 mins):Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3
...vas(SM) To Be On Exhibit at ASCO, INDIANAPOLIS, M... a Statistic," "Why Me?" The voices of people,affe...ative at an exhibit,featuring selected winners of ... 44th Annual American Society of Clinical,Oncology...
...so May Be Part of the Festivities, NEW YORK, May ...ip for a Drug-Free America(R) and MetLife Foundati...ith alcohol and drugs at,prom and graduation parti...s at their own,proms or graduations were likely to...
...o Discuss Solutions, BOSTON, May 29 The Global B...ental Health, a network of senior business,executi...orum on Mental,Health and Productivity at Harvard ... their families., The forum will address the redu...
...RAC, the,independent, non-profit accreditation org...it has developed to help case management,practitio... they provide.,The one-page survey instrument is a...cy makers, consumers, health care,management organ...
...ble or Improve in 83% of Patients ...RNewswire-FirstCall/ - Novadaq(R) Technologies Inc...ging and image guidance,systems for the operating ...the OPTTX(R) System in commercial practice at the,...
...wswire-FirstCall/ -- Mindray,Medical International...cturer,and marketer of medical devices worldwide, ...xecutive vice president of strategic development a...day,June 17, 2008 to Thursday, June 19, 2008., Mr...
Other Medicine News:Health News:Art Exhibit Honors National Cancer Survivors Day 2Health News:Art Exhibit Honors National Cancer Survivors Day 3Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 2Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 3Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 4Health News:Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties 5Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 2Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 3Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 4Health News:URAC Develops New Case Management Patient Satisfaction Tool, Invites Public Input On Voluntary Survey Instrument 2Health News:URAC Develops New Case Management Patient Satisfaction Tool, Invites Public Input On Voluntary Survey Instrument 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 4Health News:Mindray to Attend Morgan Stanley China Summit 2008 2
(Date:11/30/2009)...ov. 30 Reportlinker.com announces ...its catalogue: ,, Outsourcing Opportunities in...ww.reportlinker.com/p0165747/Outsourcing-Opportuni...cription ,, Medical devices form one of the lar...ated size of $250 billion in 2009 and a growth rat...
(Date:11/30/2009)...Nov. 30 StemCyte, Inc. concluded a...t with Academia Sinica, the National Laboratory of...lectual Property (IP) related to the treatment of ...P was pioneered by a team led by Professor John Li...sor Lin is currently the exclusive collaborator wi...
(Date:11/30/2009)...Pa., Nov. 30 Cytokine PharmaScienc... I study of CPSI-2364, its orally active, small-mo...d other pro-inflammatory cytokines. Results of th... healthy volunteers confirm the safety of this com...enrolled subjects completed the study, including t...
Breaking Medicine Technology:Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 1Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 2Baby boomers boon 3F LED light and green tea cream to smooth facial wrinkles 9842 1Toward a nanomedicine for brain cancer 9839 1
TheraSeed devices
Non-Sterile Oncoseed (Iodine-125 Seeds)
Ocular Thorpe Four Mirror Gonio
Ocular Maxfield AC Four Mirror Gonio
Medicine Products: